Blog

Trump’s FDA Cuts Are Putting Drug Development at Risk

Written by

New SEC filings from pharmaceutical companies reveal Donald Trump and Elon Musk’s cost-cutting measures could slow drug research and delay FDA approvals.

Leave a Reply

Your email address will not be published. Required fields are marked *